Jia J - Search Results

1

Experimental study of the inhibition of human hepatocarcinoma Bel7402 cells by the tripeptide tyroserleutide(YSL).

Lu R, Jia J, Bao L, Fu Z, Li G, Wang S, Wang Z, Jin M, Gao W, Yao Z. Lu R, et al. Among authors: jia j. Cancer Chemother Pharmacol. 2006 Jan;57(2):248-56. doi: 10.1007/s00280-005-0046-z. Epub 2005 Jul 19. Cancer Chemother Pharmacol. 2006. PMID: 16028100

2

Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402.

Jia J, Lu R, Qiu S, Li H, Che X, Zhao P, Jin M, Yang H, Lin G, Yao Z. Jia J, et al. Cancer Biol Ther. 2005 Sep;4(9):993-7. doi: 10.4161/cbt.4.9.1968. Epub 2005 Sep 23. Cancer Biol Ther. 2005. PMID: 16082190 Free article.

3

The effect of tripeptide tyroserleutide (YSL) on animal models of hepatocarcinoma.

Yao Z, Lu R, Jia J, Zhao P, Yang J, Zheng M, Lu J, Jin M, Yang H, Gao W. Yao Z, et al. Among authors: jia j. Peptides. 2006 Jun;27(6):1167-72. doi: 10.1016/j.peptides.2005.02.026. Epub 2005 Aug 29. Peptides. 2006. PMID: 16129512

4

Expression of PTEN, p27, p21 and AKT mRNA and protein in human BEL-7402 hepatocarcinoma cells in transplanted tumors of nude mice treated with the tripeptide tyroservatide (YSV).

Zhu Z, Jia J, Lu R, Lu Y, Fu Z, Zhao L, Wang L, Jin M, Zhao L, Gao W, Yao Z. Zhu Z, et al. Among authors: jia j. Int J Cancer. 2006 Mar 15;118(6):1539-44. doi: 10.1002/ijc.21501. Int J Cancer. 2006. PMID: 16184552

5

Gene-chip analysis of the effect of tripeptide tyroservatide (YSV) on gene-expression in human hepatocarcinoma BEL-7402 tumors transplanted to nude mice.

Jia J, Lu R, Zhou C, Zhao L, Fu Z, Zhu Z, Wang L, Zheng M, Yang J, Zhang Y, Yao Z. Jia J, et al. Mol Carcinog. 2006 Mar;45(3):197-203. doi: 10.1002/mc.20172. Mol Carcinog. 2006. PMID: 16353255

6

Inhibition of five xenografted human cancers and two murine cancers by the tripeptide tyroservatide.

Fu Z, Lu R, Jia J, Zhao L, Ma R, Lv JQ, Li XL, Chen LJ, Zhang HL, Wang L, Yao Z. Fu Z, et al. Among authors: jia j. Anticancer Drugs. 2007 Apr;18(4):467-70. doi: 10.1097/CAD.0b013e328017766a. Anticancer Drugs. 2007. PMID: 17351399

7

Effects of tyroserleutide on gene expression of calmodulin and PI3K in hepatocellular carcinoma.

Zhao L, Zhao Q, Lu R, Fu Z, Zhu Z, Jia J, Wang S, Shi L, Jian X, Yao Z. Zhao L, et al. Among authors: jia j. J Cell Biochem. 2008 Feb 1;103(2):471-8. doi: 10.1002/jcb.21409. J Cell Biochem. 2008. PMID: 17546603

8

Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay.

Li XL, Liu JY, Lu R, Xu Q, Zhu ZF, Wang L, Zhou CL, Jia J, Fu Z, Yao Z. Li XL, et al. Among authors: jia j. Invest New Drugs. 2008 Dec;26(6):525-9. doi: 10.1007/s10637-008-9121-8. Epub 2008 Feb 9. Invest New Drugs. 2008. PMID: 18264678

9

Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation.

Zhu ZF, Chen LJ, Lu R, Jia J, Liang Y, Xu Q, Zhou CL, Wang L, Wang S, Yao Z. Zhu ZF, et al. Among authors: jia j. BMC Cancer. 2008 Nov 25;8:342. doi: 10.1186/1471-2407-8-342. BMC Cancer. 2008. PMID: 19025669 Free PMC article.

10

[Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay].

Shi LX, Lu R, Wang L, Zhou CL, Xu Q, Zhu ZF, Ma R, Zhang HL, Jia J, Fu Z, Yao Z. Shi LX, et al. Among authors: jia j. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):725-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173797 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,387 results

Search Page

Filters